MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
(METEOR-CRATR Trial)
Trial Summary
What is the purpose of this trial?
This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally advanced cervical and pancreatic cancer.
Research Team
Cliff Robinson, M.D.
Principal Investigator
Washington University School of Medicine
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive definitive-intent chemoradiotherapy with biospecimen collection and imaging
Follow-up
Participants are monitored for changes in tumor microenvironment and safety
Treatment Details
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor
National Cancer Institute (NCI)
Collaborator